All sponsors

H. Lundbeck A/S $HLUN-B.CO

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS9
PHASE 3 / 2-34
RECRUITING5
READOUTS ≤12 MONTHS3
READOUT SLIPPED >6 MO71%

Delay Index: of 7 active trials registered more than a year ago, 5 have moved their primary completion (readout) date by more than 6 months since first registration (median +21.1 months). See all sponsors →

Open H. Lundbeck A/S on the live radar map → 📅 $HLUN-B.CO readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
AMULET
NCT05104476
P2Active, not recruitingMultiple System Atrophy642023-11-16 (+6 mo)
Lu AG13909
NCT05669950
P1/2RecruitingCongenital Adrenal Hyperplasia422026-09-30 (+21 mo)
PROSPECT-2
NCT04965675
P3RecruitingChronic Migraine in Children2852027-03-26 (+30 mo)
PROSPECT-1
NCT05897320
P3RecruitingEpisodic Migraine3152027-07-06 (+32 mo)
BalanCeD
NCT06471829
P2Active, not recruitingCushing's Disease162027-08-10 (+18 mo)
MASCOT
NCT06706622
P3Active, not recruitingMultiple System Atrophy4012028-02-17
REJOIN
NCT05164172
P3RecruitingMigraine6002028-04-30 (+32 mo)
DARE2
NCT07514858
P2RecruitingParkinson's Disease1502028-10-03
Asedebart
NCT07859293
P2Not yet recruitingAdrenal Hyperplasia, Congenital452031-07-31